Member Info for shandypants2

cash down from £1.2m to £255k in 6 months on £1m revenues. Less good.

no - they said they were funded for the next 12 months only recently (i think)

could do with a trading update, not only to update on progress but also put some life into the share price. Notice there was one early Oct last year so hopefully we'll get one in the next 2 or 3 weeks.

we know the results for last year - it's the trading update that is key.

Surely products should be selling like hot cakes at the moment. If this is translated into increased profits then could re-rate.

The technology is not in question

still loss making and will be for some time. Not quite sure why so much positivity IMHO

another mini pump and dump.

Hopefully a juicy RNS is not far away but i'm not holding my breathe

herit - we'll know for sure when H1 numbers are published but i'm estimating c£500k a month.

This is based on c£2m pa for admin/wages (was £3m in 2019 but should drop substantially) and £4m pa depreciation (Argo has stated it depreciates over a 3 year period). This is higher than 2019 but we've bought more machines.

it is main market. Also the PE of 10 should be based on the E i.e profit not revenue.

So assuming it makes say £3m PAT this year then conservatively it is worth £30m. A more realistic PE is 20 for a growing company so that's £60m. Undervalued however you slice and dice it

it definitely indicates that the market is confident that this deal will go through

itshenderz - IMHO interims won't be significant. Covid must have slowed down potential growth in Europe and guessing not much has happened in China regarding progressing regulatory approval. Last year interims were reported in August and we are already in Sept. I suspect STX will want to delay them until an US deal is announced, however, they must be reported this month so it should be an interesting few weeks.
Re cash at H1 last year STX had £6.6m and at year end £4.1m so cash burn c £5m a year. on 30/4 STX announced we had £10.4m so i'm pretty relaxed on that front. Think STX only has 12 employees.
As per FDA announcement last year a few nervous investors will sell but those remaining will hopefully be well rewarded.

Bydna - £ has improved against dollar in last few weeks so that will account for revenue being slightly lower than expected as Argo report in £.

Decent monthly figures really c£700k gross profit. Admin and depreciation needs deducting but a decent net profit

yes agree, ok is about right.

Noticed that 70% of output has been hedged at $35 in H2 - so with Brent at c$45 now, does that mean we get the current price but if it slips below $35 we still get $35? Shame they didn't think of this for H1!!!

i thought it a bit on the low side too. I suspect No 2 is a more logical explanation.
No real concerns if BOPD has reduced by 5% ish . More than that would be worrying.

LR talks of updated economics, an updated scoping study and a pre feasibility study.

Any idea in what order they will be delivered and how long each might take. Assume PFS will only occur after more drilling, is it the same with the other 2?
Thanks in advance

still buying. Large order late Friday and another this AM suggests he's still accumulating

clearly good news, our biggest holder has taken another 2%. A great vote of confidence

Chesh - yes i was concerned at cash levels within SKIN and since then we've done 2 loans for £400k and £3m at 5% and 12.5% respectively. Sort of proves my point i think.

Let's wait for H1 results - cash at 31/12/19 was £1.2m (despite £1.3m raise in early Dec). Guessing cash will be substantially down and SKIN will still be making a loss.

However, based on last few RNSs this company is clearly going places. An instant covid water detection will be transformational, hence the share price increase recently. The MWG deal always looked better for them than SKIN so merging the 2 makes sense IMHO.

Still think we'll need money in 2021, as these loans will need to be repaid, however, a placing for say 10% of company at 2 or 3 times current share price (with no warrants) is not necessarily a bad thing.

i think the risk is minimal IMHO. Topped up today - did so buying MWG only as it's 10% less than SKIN.

Did the same with Hvivo and OO late last year too and made a nice profit

we seem in limbo atm with no CEO and all operations being run from Australia whilst 90% of revenue is earned in the UK.
We need an UK CEO asap IMHO.

Hopefully results and progress announced in Sept will be positive. Can't see any news dropping before then

also a slow and steady rise in Brent price - now c$46 a barrel. In the short term with no changes to daily production levels an increase in the brent price is the only way monthly revenue will increase, yet share price steadily falls